Investor contact
We are currently open for fundraising pre-seed investments
Investment size
Total:
200k CHF
Status:
25k CHF confirmed
Phase 1
Product launch in Switzerland
Q4 2023
Fundraising time period
Close date: 30th of November 2023
Allocation of funds
Phase 2
Gaining a foothold in Swiss market
-
Preventative metabolic health B2B2C market
Swiss market key metrics
2024: 100-200k CHF annual recurring revenue
2026: 1m CHF annual recurring revenue
Investor & investment type
Are you a Business Angel or Venture Capital looking for an early entry into high-impact (metabolic) healthcare solutions?
Ticket size: 25-50k CHF
Preferred profile: affinity with healthcare, network in the field and long term horizon
Convertible loan agreements (CLAs)
Terms & conditions: Standard with a discount rate of 15-18%
Phase 3
Product expansion
-
The United Kingdom &
The Netherlands
Market access
Commercial laboratory partner
- NDA signed
- Technical feasibility confirmed
- Global presence
First customer
Clinical laboratory lab chain
(10+ labs)
- Product launch partner
- Project partnership signed
- NDA signed
Second customer
Private clinic
- Project partnership signed
Go-to-market
Product launch
- Q4 2023
- Switzerland
Product expansion
- Q2 2024
- United Kingdom & The Netherlands
Product expansion
- 2025
- European market
Intellectual property
Science
- Custom developed technical method* (nuclear magnetic resonance
spectroscopy)
(IT) Technology
- Automated data processing pipeline
Data assets
- Validated metabolite identification & quantification
- Human research project ongoing (EPFL; CH)
*patenting progress pending
Regulatory
Lifestyle-advice tool
- No regulatory hurdles or additional permissions required
Capitalisation
Total raised 63.5k
Find the full list of investors and funds at Crunchbase: here
*Salaries self funded
**No non-founders at captable
Keen to explore a potential investment?
Let's start the conversation
Reach out to us
Social Media
Leave a message and we reach out to you